OMER CIK: 1285819

Omeros Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−174
FY22:
−163
FY23:
−165
FY24:
−167
FY25:
−123
(positive)
Change from FY21 to FY25
millions USD
FY21:
−170
FY22:
−158
FY23:
–
FY24:
–
FY25:
−237
(positive)
Change from FY21 to FY25
millions USD
FY21:
−192
FY22:
−182
FY23:
−175
FY24:
−180
FY25:
−2.80
(positive)
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
47.4
FY23:
−118
FY24:
−157
FY25:
−3.35

All amounts in millions USD Data sources:SEC EDGARTwelve Data